Skip to main content
Fig. 2 | Cardiovascular Diabetology – Endocrinology Reports

Fig. 2

From: DPP4 inhibitors and COVID19 outcomes in patients with type II diabetes: a multicenter retrospective cohort study in Saudi Arabia

Fig. 2

(Panel A) Unadjusted Kaplan Meir curve for the mortality outcome; (Panel B) Weighted Kaplan Meir curve for the mortality outcome. (Panel C) Unadjusted Cumulative Incidence Function (CIF) for the progression to mechanical ventilation outcome. (Panel D) Adjusted Cumulative Incidence Function (CIF) for the progression to mechanical ventilation outcome. Abbreviations: DPP4i: Dipeptidyl peptidase-4 inhibitors; HR: Hazard Ratios; CI: Confidence intervals

Back to article page